Coastal Bridge Advisors LLC Acquires Shares of 3,925 Marsh & McLennan Companies, Inc. $MRSH

Coastal Bridge Advisors LLC bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) in the 2nd quarter, Holdings Channel.com reports. The firm bought 3,925 shares of the financial services provider’s stock, valued at approximately $654,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. Brighton Jones LLC increased its stake in shares of Marsh & McLennan Companies by 51.2% in the fourth quarter. Brighton Jones LLC now owns 8,738 shares of the financial services provider’s stock worth $1,856,000 after buying an additional 2,960 shares during the last quarter. Bison Wealth LLC boosted its stake in Marsh & McLennan Companies by 39.6% during the 4th quarter. Bison Wealth LLC now owns 3,064 shares of the financial services provider’s stock valued at $651,000 after acquiring an additional 869 shares during the last quarter. Glenview Trust co increased its position in shares of Marsh & McLennan Companies by 10.8% in the 2nd quarter. Glenview Trust co now owns 3,897 shares of the financial services provider’s stock worth $852,000 after purchasing an additional 379 shares during the last quarter. Osterweis Capital Management Inc. increased its position in shares of Marsh & McLennan Companies by 18,440.0% in the 2nd quarter. Osterweis Capital Management Inc. now owns 927 shares of the financial services provider’s stock worth $203,000 after purchasing an additional 922 shares during the last quarter. Finally, Diversify Advisory Services LLC acquired a new stake in shares of Marsh & McLennan Companies in the 2nd quarter valued at about $1,307,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.

Marsh & McLennan Companies Stock Up 1.5%

Shares of NYSE MRSH opened at $192.90 on Friday. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 1.22. The stock has a 50-day simple moving average of $182.75. Marsh & McLennan Companies, Inc. has a 52-week low of $156.60 and a 52-week high of $207.82. The company has a market capitalization of $92.05 billion, a PE ratio of 23.58, a P/E/G ratio of 2.64 and a beta of 0.59.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.89 by $0.07. The company had revenue of $7.28 billion during the quarter. Marsh & McLennan Companies had a return on equity of 32.67% and a net margin of 14.24%.The firm’s revenue was up 6.2% compared to the same quarter last year. As a group, equities research analysts expect that Marsh & McLennan Companies, Inc. will post 10.44 earnings per share for the current year.

Marsh & McLennan Companies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Thursday, July 23rd were given a $0.99 dividend. This is a boost from Marsh & McLennan Companies’s previous quarterly dividend of $0.90. This represents a $3.96 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Thursday, July 23rd. Marsh & McLennan Companies’s dividend payout ratio is 48.41%.

Analyst Ratings Changes

MRSH has been the subject of a number of research reports. Citigroup downgraded Marsh & McLennan Companies from a “buy” rating to a “neutral” rating and set a $200.00 price target for the company. in a research note on Wednesday, July 22nd. Weiss Ratings upgraded Marsh & McLennan Companies from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th. UBS Group boosted their price target on Marsh & McLennan Companies from $212.00 to $216.00 and gave the company a “buy” rating in a report on Monday, July 27th. Piper Sandler dropped their price target on Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research report on Tuesday, May 26th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $203.50.

Insider Buying and Selling

In other Marsh & McLennan Companies news, insider Martin South sold 7,100 shares of the firm’s stock in a transaction on Tuesday, July 28th. The stock was sold at an average price of $189.99, for a total value of $1,348,929.00. Following the sale, the insider directly owned 16,632 shares in the company, valued at approximately $3,159,913.68. This trade represents a 29.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Paul Beswick sold 713 shares of the company’s stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $198.00, for a total transaction of $141,174.00. Following the transaction, the senior vice president owned 16,376 shares of the company’s stock, valued at $3,242,448. This represents a 4.17% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 36,469 shares of company stock valued at $6,291,345. 0.38% of the stock is owned by corporate insiders.

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.